Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03371381
Title An Efficacy and Safety Study of JNJ-64041757, a Live Attenuated Listeria Monocytogenes Immunotherapy, in Combination With Nivolumab Versus Nivolumab Monotherapy in Participants With Advanced Adenocarcinoma of the Lung
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Janssen Research & Development, LLC
Indications

lung adenocarcinoma

Therapies

JNJ-64041757 + Nivolumab

Nivolumab

Age Groups: adult | senior
Covered Countries USA | ESP | BEL

Facility Status City State Zip Country Details
Johns Hopkins Medicine - The Sidney Kimmel Comprehensive Cancer Center Baltimore Maryland 21287 United States Details
Tennessee Oncology, PLLC Nashville Tennessee 37201 United States Details
Medical Oncology Associates, PS Spokane Washington 99208-1129 United States Details
AZ Maria Middelares Gent 9000 Belgium Details
Hosp. Univ. Quiron Dexeus Barcelona 08028 Spain Details
Hosp. Gral. Univ. de Elche Elche 03203 Spain Details
Complejo Hospitalario de Jaen Jaén 23007 Spain Details
Hosp. Regional Univ. de Malaga Málaga 29010 Spain Details
Hosp. Son Llatzer Palma de Mallorca 07198 Spain Details
Hosp. Arnau de Vilanova de Valencia Valencia 46015 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field